Grufity logoGrufity logo
StocksFundsScreenerSectorsWatchlists
AKLI

AKLI - Akili Inc Stock Price, Fair Value and News

0.22USD-0.02 (-8.33%)Delayed as of 21 Feb 2024, 01:54 pm ET
Watchlist

Market Summary

USD0.22-0.02
Delayedas of 21 Feb 2024, 01:54 pm
-8.33%

AKLI Stock Price

View Fullscreen

AKLI RSI Chart

AKLI Valuation

Market Cap

18.8M

Price/Earnings (Trailing)

-0.29

Price/Sales (Trailing)

58.19

EV/EBITDA

0.88

Price/Free Cashflow

-0.27

AKLI Price/Sales (Trailing)

AKLI Profitability

Operating Margin

-114.24%

EBT Margin

-20167.80%

Return on Equity

-94.31%

Return on Assets

-69.96%

Free Cashflow Yield

-370.87%

AKLI Fundamentals

AKLI Revenue

Revenue (TTM)

323.0K

Rev. Growth (Yr)

50.79%

Rev. Growth (Qtr)

9.2%

AKLI Earnings

Earnings (TTM)

-65.2M

Earnings Growth (Yr)

-129.82%

Earnings Growth (Qtr)

-35.01%

Breaking Down AKLI Revenue

52 Week Range

0.25
(Low)(High)

Last 30 days

-40%

Last 90 days

-46.7%

How does AKLI drawdown profile look like?

AKLI Financial Health

Current Ratio

6.95

AKLI Investor Care

Shares Dilution (1Y)

0.51%

Diluted EPS (TTM)

14.17

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20230000
2022484.3K430.5K376.8K323.0K
20213.1M2.2M1.4M538.0K
20200003.9M

Tracking the Latest Insider Buys and Sells of Akili Inc

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Dec 07, 2023
shanbhag santosh
acquired
-
-
69,750
chief financial officer
Dec 07, 2023
studer jacqueline
acquired
-
-
69,750
chief legal officer
Nov 02, 2023
martucci walter edward ii
sold (taxes)
-2,091
0.3918
-5,337
-
Nov 02, 2023
shanbhag santosh
sold (taxes)
-379
0.3918
-969
chief financial officer
Nov 02, 2023
studer jacqueline
sold (taxes)
-720
0.3918
-1,840
chief legal officer
Oct 05, 2023
martucci walter edward ii
back to issuer
-
-
-2,241,620
-
Sep 11, 2023
franklin matthew
sold
-1,814
1.05
-1,728
president & coo
Sep 11, 2023
martucci walter edward ii
sold
-2,470
1.05
-2,353
chief executive officer
Sep 11, 2023
shanbhag santosh
sold
-871
1.05
-830
chief financial officer
Sep 11, 2023
studer jacqueline
sold
-1,186
1.05
-1,130
chief legal officer

1–10 of 26

Which funds bought or sold AKLI recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Feb 16, 2024
HARBOUR INVESTMENTS, INC.
unchanged
-
-18.00
145
-%
Feb 14, 2024
VANGUARD GROUP INC
reduced
-1.77
-7,268
49,378
-%
Feb 14, 2024
Temasek Holdings (Private) Ltd
unchanged
-
-711,264
5,606,090
0.03%
Feb 14, 2024
Royal Bank of Canada
added
4.54
-
1,000
-%
Feb 14, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP
added
217
10,311
16,315
-%
Feb 14, 2024
TWO SIGMA SECURITIES, LLC
added
20.23
495
7,893
-%
Feb 14, 2024
Alyeska Investment Group, L.P.
added
146
178,060
327,575
-%
Feb 14, 2024
SUVRETTA CAPITAL MANAGEMENT, LLC
unchanged
-
-237,418
1,871,300
0.09%
Feb 14, 2024
Northeast Financial Consultants Inc
unchanged
-
-3,495
27,548
-%

1–10 of 40

Are Funds Buying or Selling AKLI?

Are funds buying AKLI calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own AKLI
No. of Funds

Unveiling Akili Inc's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 13, 2024
cowen aaron
6.0%
4,699,219
SC 13G/A
Feb 12, 2024
neuberger berman group llc
7.38%
5,776,784
SC 13G
Jan 29, 2024
baillie gifford & co
5.96%
4,665,795
SC 13G/A

Recent SEC filings of Akili Inc

View All Filings
Date Filed Form Type Document
Feb 13, 2024
SC 13G/A
Major Ownership Report
Feb 12, 2024
SC 13G
Major Ownership Report
Jan 29, 2024
SC 13G/A
Major Ownership Report
Jan 05, 2024
8-K
Current Report
Dec 20, 2023
8-K
Current Report
Dec 18, 2023
8-K
Current Report
Dec 08, 2023
4
Insider Trading
Dec 08, 2023
4
Insider Trading

Peers (Alternatives to Akili Inc)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
481.9B
360.0B
0.01% 5.90%
22.22
1.34
14.24% 11.62%
96.0B
357.8B
0.71% -14.01%
11.5
0.27
10.95% 93.52%
81.6B
65.0B
9.34% 20.24%
15.57
1.26
7.86% -7.11%
42.4B
150.1B
-0.09% 8.25%
17.33
0.28
6.04% 21.35%
11.2B
14.0B
2.25% 10.28%
16.54
0.8
6.03% -8.61%
10.8B
12.1B
12.03% 47.11%
15.6
0.89
4.57% 23.40%
MID-CAP
8.8B
2.2B
0.13% 16.69%
36.12
3.97
4.50% -6.69%
7.7B
2.9B
-3.46% 1.96%
-423.79
2.71
13.16% -106.47%
2.2B
4.1B
-19.95% -33.62%
7.83
0.54
-25.26% -41.31%
SMALL-CAP
2.3B
1.3B
4.99% 11.37%
51.27
1.72
27.06% -27.04%
1.5B
1.0B
8.40% -11.51%
25.75
1.44
10.84% 30.19%
1.2B
3.0B
7.30% 124.36%
-9.39
0.39
6.98% 58.07%
43.7M
-
-0.60% -54.62%
-3.02
-
- -27.68%
17.0M
20.7M
- -15.62%
83.79
0.82
6.53% -85.60%

Akili Inc News

Latest updates
The InvestChronicle29 Jan 202408:00 am

Akili Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
Income Statement (Quarterly)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q4
Revenue9.2%114,000104,40094,80085,20075,60066,00079,00092,000105,000--
Cost Of Revenue9.5%150,000137,000125,000123,00097,00096,000112,00083,00098,000--
Gross Profit-50.0%-36,000-24,000-14,000-41,000-33,000-30,00049,00072,0007,000--
Operating Expenses-20.0%15,281,00019,095,00022,093,00024,465,00022,306,00021,695,0002,178,25218,048,00014,565,000--
  S&GA Expenses-18.2%10,648,00013,011,00014,451,00016,911,00014,948,00015,391,00013,993,00013,292,00010,526,000--
  R&D Expenses-23.8%4,633,0006,084,0007,642,0007,554,0007,358,0006,304,0005,495,0004,756,0004,039,000--
EBITDA Margin246.9%20.59-14.01-19.05-24.98-188-151-112-18.02-11.17-8.10-6.35
Interest Expenses2.1%635,000622,000618,000496,000194,000176,000173,000172,00039,000--
Income Taxes---19,000--------
Earnings Before Taxes43.2%-11,759,000-20,711,000-16,796,00053,236,000-22,493,000-21,892,000-19,611,000-18,137,000-14,774,000--
EBT Margin158.7%12.29-20.94-24.60-28.56-190-153-114-18.47-11.46-8.30-6.51
Net Income43.2%-11,759,000-20,711,000-16,815,00053,236,000-22,493,000-21,892,000-19,610,000-18,137,000-14,774,000-8,827,000-
Net Income Margin158.2%12.23-21.00-24.66-28.56-190-153-114-18.47-11.46-8.30-6.51
Free Cashflow39.3%-11,594,000-19,101,000-20,959,000-21,212,000-19,157,000-22,235,000-9,067,976-7,924,416---
Balance Sheet
(In Thousands)
Balance Sheet
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q22021Q12020Q4
Assets-16.4%93,142111,463124,597144,557165,03455,015250,77080,937251,420193,610135,80077,99120,181
  Current Assets-16.6%90,636108,724121,325141,042161,27851,27561379,7331,417243--19,155
    Cash Equivalents31.2%73,79956,26687,86954,09789,66140,63870.0076,899520110,082--18,528
  Net PPE-9.9%6447158449199961,054-1,193----1,004
Liabilities-15.6%24,04828,50032,15733,87841,16229,50113,44815,1757,7497,898--8,197
  Current Liabilities-0.8%13,04913,15111,42013,60413,14010,7215,7488,04149.00612-5.003,925
Shareholder's Equity-16.7%69,09482,96392,440110,679123,872----20.00-20.009,905
  Retained Earnings-5.8%-288,634-272,758-260,999-240,288-223,473-275,033-12,678-226,114-6,332-6,069--5.14-114,807
  Additional Paid-In Capital0.6%357,720355,738353,429350,980347,330------24.009,905
Shares Outstanding0.2%78,30978,17578,11878,02313,690-1,6801,6741,3351,158-5,5001,158
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12021Q12020Q4
Cashflow From Operations-55.7%-18,045-11,587-19,098-20,959-21,183-19,154-22,225-9,055-7,917-19.84---
  Share Based Compensation-9.9%1,6551,8372,7592,1173,1531,9692,0701,3651,748----
Cashflow From Investing293.6%37,497-19,36952,915-14,581-61,6489,997-14,984-6.00-377----
Cashflow From Financing-196.6%-1,919-647-45.00-24.00131,85410,04164.0045.00125,786243---

AKLI Income Statement

2023-09-30
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) - USD ($)
$ in Thousands
3 Months Ended9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Income Statement [Abstract]    
Revenues$ 702$ 82$ 929$ 212
Cost of revenues280123567316
Gross profit (loss)422(41)362(104)
Operating expenses:    
Research and development4,9127,55415,62921,216
Selling, general and administrative13,93616,91137,59547,250
Total operating expenses18,84824,46553,22468,466
Operating loss(18,426)(24,506)(52,862)(68,570)
Other income (expense):    
Other income1,0043463,173395
Interest expense(582)(496)(1,839)(866)
Change in estimated fair value of earn-out liabilities2,12877,8923,18277,892
Total other income2,55077,7424,51677,421
Income (loss) before income taxes(15,876)53,236(48,346)8,851
Net income (loss)(15,876)53,236(48,346)8,851
Unrealized gain on short-term investments2514217
Comprehensive income (loss)(15,851)53,250(48,325)8,858
Net income (loss)(15,876)53,236(48,346)8,851
Dividends on Series D convertible preferred stock (1,598) (7,383)
Redemption value of Series D convertible preferred stock (799) (3,692)
Net income (loss) attributable to common stockholders - basic$ (15,876)$ 50,839$ (48,346)$ (2,224)
Net income (loss) per share attributable to common stockholders - basic$ (0.2)$ 1.38$ (0.62)$ (0.16)
Net income (loss) per share attributable to common stockholders - diluted$ (0.2)$ 0.76$ (0.62)$ (0.16)
Weighted average common stock outstanding - basic78,217,87036,920,11678,149,51713,690,186
Weighted average common shares outstanding - diluted78,217,87069,830,97078,149,51713,690,186

AKLI Balance Sheet

2023-09-30
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Current assets:  
Cash and cash equivalents$ 73,799$ 54,097
Restricted cash305305
Short-term investments12,48282,034
Accounts receivable44241
Prepaid expenses and other current assets3,6084,565
Total current assets90,636141,042
Property and equipment, net644919
Operating lease right-of-use asset1,7532,596
Prepaid expenses and other long-term assets109 
Total assets93,142144,557
Current liabilities:  
Accounts payable1,2172,681
Accrued expenses and other current liabilities3,3855,616
Deferred revenue173106
Operating lease liability774826
Note payable, short term7,5004,375
Total current liabilities13,04913,604
Note payable, long term5,20910,442
Operating lease liability, net of current portion1,9282,485
Corporate bond, net of bond discount1,9991,834
Earn-out liabilities1,8415,513
Other long-term liabilities22 
Total liabilities24,04833,878
Commitments and contingencies
Stockholders' equity  
Common stock, $0.0001 par value: 1,000,000,000 shares authorized; 78,309,213 and 78,022,924 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively88
Additional paid-in capital357,720350,980
Accumulated deficit(288,634)(240,288)
Accumulated other comprehensive loss (21)
Total stockholders' equity69,094110,679
Total liabilities and stockholders' equity$ 93,142$ 144,557
AKLI
Akili, Inc., a digital medicine company, develops cognitive treatments through game-changing technologies. The company provides EndeavorRx, a computer-based testing for cognitive dysfunction across several neurology and psychiatry indications, including attention-deficit hyperactivity disorder, depressive disorder, autism spectrum disorder, multiple sclerosis, and other neuroinflammatory diseases. It offers selective stimulus management engine mechanism to activate the fronto-parietal cortex area in the brain; body brain trainer for attention, impulsivity, working memory, and goal management; and spatial navigation engine for spatial navigation, memory, and planning and organization. Akili, Inc. was founded in 2011 and is headquartered in Boston, Massachusetts.
 CEO
 WEBSITEwww.akiliinteractive.com
 EMPLOYEES111

Akili Inc Frequently Asked Questions


What is the ticker symbol for Akili Inc? What does AKLI stand for in stocks?

AKLI is the stock ticker symbol of Akili Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Akili Inc (AKLI)?

As of Tue Feb 20 2024, market cap of Akili Inc is 18.79 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of AKLI stock?

You can check AKLI's fair value in chart for subscribers.

What is the fair value of AKLI stock?

You can check AKLI's fair value in chart for subscribers. The fair value of Akili Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Akili Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for AKLI so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Akili Inc a good stock to buy?

The fair value guage provides a quick view whether AKLI is over valued or under valued. Whether Akili Inc is cheap or expensive depends on the assumptions which impact Akili Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for AKLI.

What is Akili Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue Feb 20 2024, AKLI's PE ratio (Price to Earnings) is -0.29 and Price to Sales (PS) ratio is 58.19. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. AKLI PE ratio will change depending on the future growth rate expectations of investors.